Methods of diagnosing inflammatory bowel disease

Details Methods of diagnosing inflammatory bowel disease Methods of diagnosing inflammatory bowel disease

2011-01-18

2011-01-18

Zeman, Mary K (Department: 1631)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Biological or biochemical

C702S020000, C703S011000, C703S013000, C707S700000, C436S501000

Reexamination Certificate

active

07873479

ABSTRACT:
The present invention provides methods, systems, and code for accurately classifying whether a sample from an individual is associated with inflammatory bowel disease (IBD) or a clinical subtype thereof. In particular, the present invention is useful for classifying a sample from an individual as an IBD sample using a statistical algorithm and/or empirical data. The present invention is also useful for differentiating between a clinical subtype of IBD such as Crohn's disease (CD) and ulcerative colitis (UC) using a statistical algorithm and/or empirical data. Thus, the present invention provides an accurate diagnostic prediction of IBD or a clinical subtype thereof and prognostic information useful for guiding treatment decisions.

REFERENCES:
patent: 5750355 (1998-05-01), Targan et al.
patent: 5916748 (1999-06-01), Targan et al.
patent: 5932429 (1999-08-01), Targan et al.
patent: 6033864 (2000-03-01), Braun et al.
patent: 6074835 (2000-06-01), Braun et al.
patent: 6218129 (2001-04-01), Walsh et al.
patent: 6309643 (2001-10-01), Braun et al.
patent: 2003/0204507 (2003-10-01), Li et al.
patent: 2004/0043931 (2004-03-01), Hersberg et al.
patent: 2004/0242972 (2004-12-01), Adak et al.
patent: 2005/0054021 (2005-03-01), Targan et al.
patent: 2005/0060295 (2005-03-01), Gould et al.
patent: 2005/0164929 (2005-07-01), Alvarez et al.
patent: WO 98137415 (1998-08-01), None
patent: WO 01/89361 (2001-11-01), None
patent: WO 03/053220 (2003-07-01), None
patent: WO 2004/037073 (2004-05-01), None
patent: WO 2004/048600 (2004-06-01), None
Reumaux, Dominque; Best Practice and Research Clinical Gastroenterology; Serological Markers in Inflammatory Bowel Disease; Feb. 2003; vol. 17(1); pp. 19-35.
Dubinsky, Maria C.; Clinical Utility of Serodiagnostic Testing in Suspect Pediatric Inflammatory Bowel Disease; The American Journal of Gastroenterology; vol. 96(3) 2001; pp. 758-765.
Arnott, et al., Sero-Reactivity to Microbial Components in Crohn's Disease is Associated with Disease Severity and Progression, but not NOD2/CARD15 Genotype; American Journal of Gastroenterology; 2004; 99:2376-2384; Blackwell Publishing.
Nakamura, R.M. et al. “Advances in clinical laboratory tests for inflammatory bowel disease.”Clinica Chimica Acta(2003), vol. 335, pp. 9-20.
Restriction Requirement mailed on Jun. 22, 2010 for U.S. Appl. No. 11/841,699, filed Aug. 20, 2007, 6 pages.
Augusto et al. “Development of a hybrid algorithm based on learning classifiers that improves diagnosis of inflammatory bowel disease and differentiation between Crohn's and ulcerative colitis in a six-marker system” Gastroenterology, 2006, vol. 130, No. 4, Suppl. 2, p. A323. XP009115454.
Vernier et al. “Relevance of Serologic Studies in Inflammatory Bowel Disease,” Current Gastroenterology Reports, 2004, vol. 6, No. 6, pp. 482-487. XP2009115628.
Zhao et al. “Entity identification for heterogeneous database integration—a multiple classifier system approach and empirical evaluation,” Information Systems 2005, vol. 30, No. 2, pp. 119-132. XP025366573.
Targan, S.R., Landers, C.J., Yang, H. et al., “Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease,”Gastroenterology, 2005; 128:2020-2028.
Abreu, M.T. et al., “Use of serologic tests in Crohn's disease,”Clin Perspect Gastroenterol, 2001; 155-164.
Fleshner, P.R., Vasiliauskas, E.A., Kam, L.Y. et al., “High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis,”Gut., 2001; 49(5):671-677.
Vasiliauskas, E.A., Kam, L.Y., Karp, L.C. et al., “Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics Vasiliauskas,”Gut., 2000; 47(4):487-496.
Targan, S.R., “The Utility of ANCA and ASCA in Inflammatory bowel disease,”Inflamm Bowel Dis., 1999; 5(1):61-3.
Ruemele, F.M., Targan, S.R., Levy, G. et al., “Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease,”Gastroenterology, 1998; 115(4):822-829.

Affiliated with

Also associated with

Rating

Methods of diagnosing inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of diagnosing inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing inflammatory bowel disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2660025